Engineers Gate Manager LP Blueprint Medicines Corp Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,558 shares of BPMC stock, worth $1.37 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,558
Previous 12,252 18.82%
Holding current value
$1.37 Million
Previous $1.32 Million 1.97%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $193,934 - $277,873
2,306 Added 18.82%
14,558 $1.35 Million
Q2 2024

Aug 14, 2024
SELL
$85.18 - $108.78 $461,420 - $589,261
-5,417 Reduced 30.66%
12,252 $1.32 Million
Q1 2024

May 15, 2024
BUY
$73.17 - $99.79 $879,942 - $1.2 Million
12,026 Added 213.11%
17,669 $1.68 Million
Q4 2023

Feb 14, 2024
SELL
$43.96 - $92.84 $198,699 - $419,636
-4,520 Reduced 44.48%
5,643 $520,000
Q3 2023

Nov 14, 2023
SELL
$46.9 - $66.0 $132,211 - $186,054
-2,819 Reduced 21.71%
10,163 $510,000
Q2 2023

Aug 14, 2023
BUY
$42.2 - $66.37 $287,593 - $452,311
6,815 Added 110.51%
12,982 $820,000
Q1 2023

May 15, 2023
SELL
$37.97 - $50.0 $186,318 - $245,350
-4,907 Reduced 44.31%
6,167 $277,000
Q4 2022

Feb 14, 2023
SELL
$41.06 - $66.48 $234,000 - $378,869
-5,699 Reduced 33.98%
11,074 $485,000
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $467,095 - $726,883
9,355 Added 126.11%
16,773 $1.11 Million
Q2 2022

Aug 15, 2022
BUY
$45.23 - $70.15 $164,049 - $254,434
3,627 Added 95.67%
7,418 $375,000
Q1 2022

May 16, 2022
BUY
$54.1 - $110.08 $205,093 - $417,313
3,791 New
3,791 $242,000
Q2 2021

Aug 16, 2021
SELL
$82.78 - $101.0 $424,661 - $518,130
-5,130 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$90.71 - $108.28 $212,079 - $253,158
2,338 Added 83.74%
5,130 $499,000
Q4 2020

Feb 16, 2021
BUY
$92.08 - $124.48 $9,115 - $12,323
99 Added 3.68%
2,792 $313,000
Q3 2020

Nov 16, 2020
BUY
$66.45 - $92.7 $178,949 - $249,641
2,693 New
2,693 $250,000
Q2 2020

Aug 17, 2020
SELL
$57.09 - $79.27 $894,657 - $1.24 Million
-15,671 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$48.11 - $82.22 $373,381 - $638,109
7,761 Added 98.12%
15,671 $916,000
Q4 2019

Feb 14, 2020
BUY
$66.73 - $82.59 $527,834 - $653,286
7,910 New
7,910 $634,000

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email